Status:
COMPLETED
Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine
Lead Sponsor:
Indonesia University
Collaborating Sponsors:
Walter and Eliza Hall Institute of Medical Research
Conditions:
Malaria
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Mass Drug Administration (MDA) and Mass Screening and Selective Treatment (MST) might be applied as strategies for eliminating malaria when focusing on transmission stages. Many studies either with MD...
Detailed Description
Study Site The study will be conducted at Belu regency (south latitude 90 - 100; east longitude 1240- 1260) which located in the Nusa Tenggara Timur province, central part of Indonesia. Atambua Dist...
Eligibility Criteria
Inclusion
- All villagers of the all selected clusters
Exclusion
- Pregnant women during their first trimester
- Single dose primaquine should not be given for infants less than 1 year-old, pregnant women in all trimesters of pregnancy, breast-feeding mother and patients with G6PD deficiency
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
1488 Patients enrolled
Trial Details
Trial ID
NCT01878357
Start Date
June 1 2013
End Date
November 1 2013
Last Update
January 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kecamatan Wewiku
Betun, East Nusa Tenggara, Indonesia, 85762